PPT-PSA & Prostate Cancer
Author : trish-goza | Published Date : 2016-06-23
Dan Burke Consultant Urological Surgeon UroOncology amp Complex Laparoscopic Surgery Incidence of Prostate Cancer 2008 37 051 new cases in UK 10 168 deaths from
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "PSA & Prostate Cancer" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
PSA & Prostate Cancer: Transcript
Dan Burke Consultant Urological Surgeon UroOncology amp Complex Laparoscopic Surgery Incidence of Prostate Cancer 2008 37 051 new cases in UK 10 168 deaths from Ca Prostate 101 men diagnosed every day. Matthew D. Katz, M.D.. Assistant Professor. Urologic Oncology . Robotic and Laparoscopic Surgery. University of Arkansas for Medical Sciences. Winthrop P. Rockefeller Cancer Center. Anatomy Genitourinary System. Health Problems. Dr Nick Pendleton. . . About . this. . presentation. :. The scenarios in . this. . slide. . presention. are . based. . wholly. or . partly. on real patients . who. have . presented. Norm D. Smith, M.D.. Associate Professor. Co-Director. Urologic Oncology. University of Chicago. United States Preventive Services Task Force (USPSTF). USPSTF Warns Against Blood Test For Prostate Cancer. Background A National Institutes of Health NIH panel that convened in 2011 recommended that AS151a strategy with curative intent that involves regular monitoring of PSA levels and repeat biopsies151sh Asymptomatic pt. General concern. +/- . FHx. CHAPS / IPSS / failed venesection / ?informed / ?. E. uropean guidance. Symptomatic pts (LUTS, ED, vis haem; LBP/. wt. loss). PSA (prostate-specific antigen) is a serine protease enzyme produced by prostate epithelial cells (both normal and malignant).. Andrew J Armstrong MD . ScM. FACP. National Alliance of State Prostate Cancer Coalitions Webinar Series . November 2020. Professor of Medicine and Surgery, Pharmacology and Cancer Biology. Director of Research, Duke Cancer Institute . Scott Davis : The Prostate Protocol PDF, The Prostate Protocol Ebook PDF, The Prostate Protocol PDF EBook, The Prostate Protocol Diet PDF, The Prostate Protocol Recipes PDF, The Prostate Protocol Ingredients PDF, The Prostate Protocol System EBook, The Prostate Protocol Program PDF, The Prostate Protocol Guide EBook, The Prostate Protocol Reviews PDF, The Prostate Protocol Discount EBook, The Prostate Protocol Buy EBook, The Prostate Protocol Order EBook, The Prostate Protocol Price PDF, The Prostate Protocol Amazon PDF, The Prostate Protocol Sample PDF, The Prostate Protocol Meal Plan 279 in Mexico, PC prevalence and the consequent impact of PSA screening cannot be accurately measured. Multiple fundamental prognostic factors for PC (among othershave been considered: 1. PSA determin Investigations for Prostate cancer Presentation: Diagnosis: Risk stratification (Ref) : Low risk PSA 0, Gleason score 6 (ISUP 1), DRE showing cT1 - T2a Intermediate risk: PSA 10 - 20, Scott Davis : The Prostate Protocol PDF, The Prostate Protocol Ebook PDF, The Prostate Protocol PDF EBook, The Prostate Protocol Diet PDF, The Prostate Protocol Recipes PDF, The Prostate Protocol Ingredients PDF, The Prostate Protocol System EBook, The Prostate Protocol Program PDF, The Prostate Protocol Guide EBook, The Prostate Protocol Reviews PDF, The Prostate Protocol Discount EBook, The Prostate Protocol Buy EBook, The Prostate Protocol Order EBook, The Prostate Protocol Price PDF, The Prostate Protocol Amazon PDF, The Prostate Protocol Sample PDF, The Prostate Protocol Meal Plan SWAG Urology SSG. 11. th . October 2018 . Context of PSA based screening . ERSPC and PLCO highlighted that the balance of benefits and harms in men remains close. Small mortality benefit with 2-4 yearly repeated screening, 5 instead of 6 deaths in 1000. Victoria . Sinibaldi. , RN, MS, CS, CANP, BC. Daniel P . Petrylak. , MD. . Disclosures for . Ms. . Sinibaldi. No financial interests or affiliations to disclose. Disclosures for Dr . Petrylak. Consulting Agreements. Dr Marie-Pier St-Laurent, MD, FRCSC. Urologic-Oncology fellow, UBC. Research scientist, Vancouver Prostate Centre. Honorarium: Bayer, PCSC. As a urologist, I am biased towards prostate cancer screening.. In association with. What is Prostate Cancer?. Prostate cancer affects 1 in 8 males. And 1 in 4 African – Caribbean men . The Prostate . What is Prostate Cancer?. What are the risk factors?. Age.
Download Document
Here is the link to download the presentation.
"PSA & Prostate Cancer"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents